HRT Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-275,716
| Closed | -$1.34M | – | 2522 |
|
|
2025
Q1 | $1.34M | Buy |
+275,716
| New | +$1.34M | 0.01% | 846 |
|
|
2024
Q3 | – | Sell |
-125,357
| Closed | -$854K | – | 2407 |
|
|
2024
Q2 | $854K | Buy |
+125,357
| New | +$854K | ﹤0.01% | 1004 |
|
|
2023
Q4 | – | Sell |
-250,946
| Closed | -$853K | – | 2293 |
|
|
2023
Q3 | $853K | Buy |
+250,946
| New | +$853K | 0.01% | 993 |
|
|
2022
Q4 | – | Sell |
-32,142
| Closed | -$674K | – | 2421 |
|
|
2022
Q3 | $674K | Buy |
+32,142
| New | +$674K | 0.01% | 1197 |
|
|
2022
Q2 | – | Sell |
-5,108
| Closed | -$209K | – | 2979 |
|
|
2022
Q1 | $209K | Buy |
+5,108
| New | +$209K | ﹤0.01% | 2213 |
|
|
2019
Q2 | – | Sell |
-4,073
| Closed | -$205K | – | 767 |
|
|
2019
Q1 | $205K | Buy |
+4,073
| New | +$205K | 0.03% | 358 |
|